Biomedicines 9(2):145 Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K (2013) Gut microbiota and non-alcoholic fatty liver disease: new insights
Michigan's insurance market has seen significant cost pressure on weight-loss GLP-1 coverage: BCBS of Michigan ended weight-loss GLP-1 coverage for fully insured large-group plans effective January 1, 2025, signaling a statewide pattern of benefit tightening
Liraglutide is being developed by Novo Nordisk, a Danish multinational pharmaceutical company developing innovative biological medicines
This phenomenon is especially common with rapid weight loss, whether through lifestyle changes, bariatric surgery, or medications like semaglutide or tirzepatide
However, weight loss should not be the primary reason for choosing either medication for diabetes treatment
First, other than certain preventive services where coinsurance and the Part B deductible are waived to comply with sections 1833(a)(1) and (b) of the Act, the ASC coinsurance rate for all procedures is 20 percent